Agenus Inc. will host its first Stakeholder Webcast of 2026, titled "Access to Acceleration: Agenus' Global Momentum Entering 2026," on Wednesday, January 28, 2026, at 4:00 p.m. ET. The event will focus on expanding global access pathways, strategic partnerships, and operational readiness for the company's botensilimab and balstilimab (BOT+BAL) program. The session will include insights from Agenus leadership and international oncology experts, with discussion on clinical development, authorized access programs, and priorities for the coming year.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agenus Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260120995688) on January 20, 2026, and is solely responsible for the information contained therein.